ALLARITY THERAPEUTICS INC
(NASDAQ: ALLR)
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
0.680
-
(-%)
Range
0.662 - 0.719
(8.61%)
Open
-
Previous Close
0.680
Bid Price
0.274
Bid Volume
29
Ask Price
0.277
Ask Volume
8
Volume
2,827,211
Value
-
Remark
Delayed prices. Updated at 17 May 2024 01:33.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
